학술논문
Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry.
Document Type
Article
Author
Conway, Richard; Nikiphorou, Elena; Demetriou, Christiana A; Low, Candice; Leamy, Kelly; Ryan, John G; Kavanagh, Ronan; Fraser, Alexander D; Carey, John J; O'Connell, Paul; Flood, Rachael M; Mullan, Ronan H; Kane, David J; Ambrose, Nicola; Stafford, Frances; Robinson, Philip C; Liew, Jean W; Grainger, Rebecca; McCarthy, Geraldine M; Alliance, the COVID-19 Global Rheumatology
Source
Subject
*EVALUATION of medical care
*OBESITY
*HUMAN research subjects
*MORTALITY
*FISHER exact test
*INFORMED consent (Medical law)
*MATHEMATICAL variables
*HOSPITAL care
*CHI-squared test
*DESCRIPTIVE statistics
*RHEUMATISM
*SMOKING
*SOCIODEMOGRAPHIC factors
*LOGISTIC regression analysis
*DATA analysis software
*COVID-19 pandemic
*GOUT
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1462-0324
Abstract
Objectives Although evidence is accumulating globally, data on outcomes in rheumatic disease and COVID-19 in Ireland are limited. We used data from the COVID-19 Global Rheumatology Alliance (C19-GRA) to describe time-varying COVID-19 outcomes for people with rheumatic disease in Ireland. Methods Data entered into the C19-GRA provider registry from Ireland between 24 March 2020 and 9 July 2021 were analysed. Differences in the likelihood of hospitalization and mortality according to demographic and clinical variables were investigated using Chi-squared test or Fisher's exact test, as appropriate. Trends in odds of hospitalization and mortality over time were investigated using logistic regression with the time period as a categorical variable. Results Of 212 cases included, 59.4% were female and median age was 58.0 years (range 13–96). Of the 212 cases, 92 (43%) were hospitalized and 22 (10.4%) died. Increasing age, a diagnosis of gout, ever smoking, glucocorticoid use, having comorbidities and specific comorbidities of cancer, cardiovascular and pulmonary disease were more common in those hospitalized. A diagnosis of inflammatory arthritis, csDMARD and/or b/tsDMARD use were less frequent in those hospitalized. Increasing age, a diagnosis of gout, ever smoking, having comorbidities and specific comorbidities of obesity, cardiovascular and pulmonary disease were more common in those who died. Odds of hospitalization or mortality did not change over time. Conclusion No temporal trend was observed in either COVID-19-related hospitalization or mortality outcomes for people with rheumatic disease in Ireland. [ABSTRACT FROM AUTHOR]